Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Senior who wrote (18165)	12/10/2003 12:03:57 PM
From: Sepster	Read Replies (2) of 78753

It appeared to me that legal issues with PLMD were already factored into the stock. It provides products, such as diabetes testing kits, which require repruchases. I think the direct-to-consumer medical supply business is a growing market. It's revenues and net income have been consistently increasing: Revenue: 2000: 156.9m; 2001: 220m; 2002: 279.7m; 2003: 356.2m NetInc.: 2000: 16.5m; 2001: 29.7m; 2002: 30.4m; 2003: 40.2m Cash flow: 2000: 29.5m; 2001: 54.5m; 2002: 66.4m; 2003: 82.9m Similarly ROE has been increasing; low debt. and it appears to me to undervalued. I would not expect major gains in the stock but I would think it would have steady upward movement in price consistent with its earnings. Septster

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next